Common research-context range: 50-200 mg per dose for intranasal sprays or sublingual troches, dosed daily or several times weekly
Future research will be necessary to develop effective therapies to treat or prevent CoQ 10 deficiency
Loading Phase (Weeks 1 to 6) Goal: Introduce the peptide, check for tolerance, begin biological activity Dose: 1 to 2 mg, two times a week Track: Photos, notes, how the patient feels Transition Phase (Weeks 7 to 12) Goal: See what is working, adjust if needed Dose: Stay where you are or drop to once a week if progress stalls Ask: What feels better
Posted on behalf of Cedars Sinai Medical Office Towers 8631 West 3rd Street, #545E Los Angeles, CA 90048 Phone: (310) 361-5480 Mon Thu: 8:30am 6:00pm Friday: 8:30am 4:30pm
2023;5:vdad009
Follow all the instructions given by your doctor before using the Ubinext-LC tablet